D.A. DAVIDSON & CO. - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 28 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
D.A. DAVIDSON & CO. ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$17,000
+112.5%
49,500
+22.2%
0.00%
Q1 2020$8,000
-11.1%
40,5000.0%0.00%
Q4 2019$9,0000.0%40,5000.0%0.00%
Q3 2019$9,000
-10.0%
40,5000.0%0.00%
Q2 2019$10,000
-71.4%
40,500
-44.5%
0.00%
-100.0%
Q1 2019$35,000
+25.0%
73,0000.0%0.00%0.0%
Q4 2018$28,000
-48.1%
73,0000.0%0.00%0.0%
Q3 2018$54,000
+45.9%
73,000
+25.9%
0.00%0.0%
Q2 2018$37,000
+76.2%
58,0000.0%0.00%
Q1 2018$21,000
-79.8%
58,000
-63.1%
0.00%
-100.0%
Q4 2017$104,000
+285.2%
157,000
+227.1%
0.00%
+100.0%
Q3 2017$27,000
-82.7%
48,000
-62.5%
0.00%
-75.0%
Q2 2017$156,000
-19.2%
128,0000.0%0.00%
-20.0%
Q1 2017$193,000
+96.9%
128,000
+14.3%
0.01%
+150.0%
Q4 2016$98,000
-42.7%
112,000
-11.8%
0.00%
-50.0%
Q3 2016$171,000
+7.5%
127,000
+41.1%
0.00%
-20.0%
Q2 2016$159,000
-11.2%
90,0000.0%0.01%
-16.7%
Q1 2016$179,000
+11.2%
90,000
+80.0%
0.01%
+20.0%
Q4 2015$161,00050,0000.01%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 90,000$222,0000.17%
EQUITEC SPECIALISTS, LLC 21,820$54,0000.02%
TFS CAPITAL LLC 46,886$116,0000.01%
Westend Capital Management, LLC 1,000$3,0000.00%
A.R.T. Advisors, LLC 33,414$82,0000.00%
Virtu KCG Holdings LLC 31,765$78,0000.00%
RHUMBLINE ADVISERS 14,080$35,0000.00%
BNP PARIBAS FINANCIAL MARKETS 1,115$2,754,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 151,489$374,0000.00%
BlackRock Investment Management, LLC 73,717$182,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders